Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
Oncotarget
|
December 5, 2014
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer
Ryunosuke Kogo, Christine How, Naz Chaudary, et al.
RSC Medicinal Chemistry
|
October 16, 2025
Development of small molecule inhibitors of ECM collagen secretion
Ross S Mancini, Pierre-Antoine Bissey, Leonardo Massignan, et al.
Oncogenesis
|
May 26, 2018
Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Jacqueline H Law, Jeff P Bruce, et al.
Molecular Cancer Therapeutics
|
September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
Kenneth W Yip, Emma Ito, Xinliang Mao, et al.
BMC Cancer
|
June 27, 2020
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Mona Teng, Jacqueline H Law, et al.
Plos One
|
May 24, 2014
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma
Justin P Williams, Inki Kim, Emma Ito, et al.
JAMA Network Open
|
November 11, 2020
Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema
Jennifer Yin Yee Kwan, Petra Famiyeh, Jie Su, et al.
Oncotarget
|
March 3, 2016
MiR-449a promotes breast cancer progression by targeting CRIP2
Wei Shi, Jeff Bruce, Matthew Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen
Kenneth W Yip, Xinliang Mao, P Y Billie Au, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer
Kenneth W Yip, Wei Shi, Melania Pintilie, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
Oncotarget
|
December 5, 2014
The microRNA-218~Survivin axis regulates migration, invasion, and lymph node metastasis in cervical cancer
Ryunosuke Kogo, Christine How, Naz Chaudary, et al.
RSC Medicinal Chemistry
|
October 16, 2025
Development of small molecule inhibitors of ECM collagen secretion
Ross S Mancini, Pierre-Antoine Bissey, Leonardo Massignan, et al.
Oncogenesis
|
May 26, 2018
Dysregulation of the MiR-449b target TGFBI alters the TGFβ pathway to induce cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Jacqueline H Law, Jeff P Bruce, et al.
Molecular Cancer Therapeutics
|
September 21, 2006
Potential use of alexidine dihydrochloride as an apoptosis-promoting anticancer agent
Kenneth W Yip, Emma Ito, Xinliang Mao, et al.
BMC Cancer
|
June 27, 2020
MiR-34c downregulation leads to SOX4 overexpression and cisplatin resistance in nasopharyngeal carcinoma
Pierre-Antoine Bissey, Mona Teng, Jacqueline H Law, et al.
Plos One
|
May 24, 2014
Pre-clinical characterization of Dacomitinib (PF-00299804), an irreversible pan-ErbB inhibitor, combined with ionizing radiation for head and neck squamous cell carcinoma
Justin P Williams, Inki Kim, Emma Ito, et al.
JAMA Network Open
|
November 11, 2020
Development and Validation of a Risk Model for Breast Cancer-Related Lymphedema
Jennifer Yin Yee Kwan, Petra Famiyeh, Jie Su, et al.
Oncotarget
|
March 3, 2016
MiR-449a promotes breast cancer progression by targeting CRIP2
Wei Shi, Jeff Bruce, Matthew Lee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 27, 2006
Benzethonium chloride: a novel anticancer agent identified by using a cell-based small-molecule screen
Kenneth W Yip, Xinliang Mao, P Y Billie Au, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 6, 2006
Prognostic significance of the Epstein-Barr virus, p53, Bcl-2, and survivin in nasopharyngeal cancer
Kenneth W Yip, Wei Shi, Melania Pintilie, et al.
Page
of 4